CD40 Gene Polymorphisms Associated with Susceptibility and Coronary Artery Lesions of Kawasaki Disease in the Taiwanese Population
暂无分享,去创建一个
Mei-Chyn Chao | Ying-Chi Lin | Ming-Feng Hou | Ho-Chang Kuo | Kuender D Yang | M. Hou | Wei-Chiao Chang | Hong-Ren Yu | Wei-Chiao Chang | M. Chao | Ying-Hsien Huang | Chi-Di Liang | Hong-Ren Yu | Chih-Lu Wang | Kuender D. Yang | Yu-Wen Hsu | H. Kuo | Ying-Chi Lin | Ying-Hsien Huang | Yu-Wen Hsu | C. Liang | Chih‐Lu Wang
[1] Lei Wan,et al. Influence of interleukin 18 promoter polymorphisms in susceptibility to Kawasaki disease in Taiwan. , 2008, The Journal of rheumatology.
[2] I-Chun Lin,et al. ITPKC Single Nucleotide Polymorphism Associated with the Kawasaki Disease in a Taiwanese Population , 2011, PloS one.
[3] Kuender D Yang,et al. A unique plasma proteomic profiling with imbalanced fibrinogen cascade in patients with Kawasaki disease , 2009, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[4] Kuender D Yang,et al. The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease , 2007, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[5] C. Langefeld,et al. Variants of the CD40 gene but not of the CD40L gene are associated with coronary artery calcification in the Diabetes Heart Study (DHS). , 2006, American heart journal.
[6] Mei-Chyn Chao,et al. Polymorphisms of transforming growth factor-β signaling pathway and Kawasaki disease in the Taiwanese population , 2011, Journal of Human Genetics.
[7] T Enright,et al. Kawasaki syndrome. , 1990, Annals of allergy.
[8] Kao-Pin Hwang,et al. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease , 2010, Acta paediatrica.
[9] J. Mehta,et al. LOX-1, an Oxidized LDL Endothelial Receptor, Induces CD40/CD40L Signaling in Human Coronary Artery Endothelial Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[10] Walter R Wilson,et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association , 2004, Circulation.
[11] E. Shapiro,et al. Association between a Novel Human Coronavirus and Kawasaki Disease , 2005, The Journal of infectious diseases.
[12] H. Takada,et al. Th1 and Th2 cytokine production is suppressed at the level of transcriptional regulation in Kawasaki disease , 2004, Clinical and experimental immunology.
[13] Kuender D Yang,et al. Lack of Association between ORAI1/CRACM1 Gene Polymorphisms and Kawasaki Disease in the Taiwanese Children , 2011, Journal of Clinical Immunology.
[14] Kuender D Yang,et al. Decreased nitric oxide production after intravenous immunoglobulin treatment in patients with Kawasaki disease. , 2002, The Journal of pediatrics.
[15] L. Jonides,et al. Kawasaki disease. , 1994, Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners.
[16] Chien-Fu Huang,et al. Association of lower eosinophil‐related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease , 2009, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[17] I. Park,et al. Kawasaki Disease in Korea, 2003–2005 , 2007, The Pediatric infectious disease journal.
[18] Reinhold Förster,et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells , 1998, Nature.
[19] B. Berkhout,et al. Lack of Association between Infection with a Novel Human Coronavirus (HCoV), HCoV-NH, and Kawasaki Disease in Taiwan , 2006, The Journal of infectious diseases.
[20] T Kobayashi,et al. Increased CD11b expression on polymorphonuclear leucocytes and cytokine profiles in patients with Kawasaki disease , 2007, Clinical and experimental immunology.
[21] H. Yanagawa,et al. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. , 1974, Pediatrics.
[22] T. Ebihara,et al. Lack of Association between New Haven Coronavirus and Kawasaki Disease , 2005, The Journal of infectious diseases.
[23] Yusuke Nakamura,et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms , 2008, Nature Genetics.
[24] Kuender D Yang,et al. Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease. , 2003, Pediatrics.
[25] C. Stefanadis,et al. The CD40/CD40 ligand system: linking inflammation with atherothrombosis. , 2009, Journal of the American College of Cardiology.
[26] Chien-Fu Huang,et al. CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese children , 2011, Journal of Human Genetics.
[27] B. Pamukcu,et al. The CD40-CD40L system in cardiovascular disease , 2011, Annals of medicine.
[28] Yusuke Nakamura,et al. CD40 ligand gene and Kawasaki disease , 2004, European Journal of Human Genetics.
[29] A. Nezos,et al. CD40/CD40L signaling and its implication in health and disease , 2009, BioFactors.
[30] Shih-Feng Tsai,et al. IL-10 Promoter Genetic Polymorphisms and Risk of Kawasaki Disease in Taiwan , 2011, Disease markers.
[31] Hack‐Ki Kim,et al. Kawasaki disease in Korea , 1992 .
[32] I-Chun Lin,et al. CTLA-4, Position 49 A/G Polymorphism Associated with Coronary Artery Lesions in Kawasaki Disease , 2011, Journal of Clinical Immunology.
[33] F. Huang,et al. Genetic Polymorphisms in the CD40 Ligand Gene and Kawasaki Disease , 2008, Journal of Clinical Immunology.
[34] Stefanie Dimmeler,et al. CD40 and vascular inflammation. , 2004, The Canadian journal of cardiology.
[35] Hiroyuki Ohashi,et al. Elevated Levels of High-Sensitivity C-Reactive Protein and Serum Amyloid-A Late After Kawasaki Disease: Association Between Inflammation and Late Coronary Sequelae in Kawasaki Disease , 2005, Circulation.
[36] Shoichi Ozaki,et al. A novel anti‐peroxiredoxin autoantibody in patients with Kawasaki disease , 2012, Microbiology and immunology.
[37] J. Chun,et al. Elevated anti‐α‐enolase antibody levels in Kawasaki disease , 2008, Scandinavian journal of rheumatology.